N K Dunbar1, E E Richards1, D Woldeyohannes2, R Van den Bergh3, E Wilkinson4, D Tamang5, P Owiti6,7. 1. Ministry of Health, Monrovia, Liberia. 2. Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia. 3. Médecins Sans Frontières-Operational Centre Brussels, Brussels, Belgium. 4. Institute of Medicine, University of Chester, Chester, UK. 5. International Union Against Tuberculosis and Lung Disease, South East Asia Office, New Delhi, India. 6. Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya. 7. International Union Against Tuberculosis and Lung Disease, Paris, France.
Abstract
Setting: The malaria-endemic country of Liberia, before, during and after the 2014 Ebola outbreak. Objective: To describe the consequences of the Ebola outbreak on Liberia's National Malaria Programme and its post-Ebola recovery. Design: A retrospective cross-sectional study using routine countrywide programme data. Results: Malaria caseloads decreased by 47% during the Ebola outbreak and by 11% after, compared to the pre-Ebola period. In those counties most affected by Ebola, a caseload reduction of >20% was sustained for 12 consecutive months, while this lasted for only 4 consecutive months in the counties least affected by Ebola. Linear regression of monthly proportions of confirmed malaria cases-as a proxy indicator of programme performance-over the pre- and post-Ebola periods indicated that the malaria programme could require 26 months after the end of the acute phase of the Ebola outbreak to recover to pre-Ebola levels. Conclusions: The differential persistence of reduced caseloads in the least- and most-affected counties, all of which experienced similar emergency measures, suggest that factors other than Ebola-related security measures played a key role in the programme's reduced performance. Clear guidance on when to abandon the emergency measures after an outbreak may be needed to ensure faster recovery of malaria programme performance.
Setting: The malaria-endemic country of Liberia, before, during and after the 2014 Ebola outbreak. Objective: To describe the consequences of the Ebola outbreak on Liberia's National Malaria Programme and its post-Ebola recovery. Design: A retrospective cross-sectional study using routine countrywide programme data. Results:Malaria caseloads decreased by 47% during the Ebola outbreak and by 11% after, compared to the pre-Ebola period. In those counties most affected by Ebola, a caseload reduction of >20% was sustained for 12 consecutive months, while this lasted for only 4 consecutive months in the counties least affected by Ebola. Linear regression of monthly proportions of confirmed malaria cases-as a proxy indicator of programme performance-over the pre- and post-Ebola periods indicated that the malaria programme could require 26 months after the end of the acute phase of the Ebola outbreak to recover to pre-Ebola levels. Conclusions: The differential persistence of reduced caseloads in the least- and most-affected counties, all of which experienced similar emergency measures, suggest that factors other than Ebola-related security measures played a key role in the programme's reduced performance. Clear guidance on when to abandon the emergency measures after an outbreak may be needed to ensure faster recovery of malaria programme performance.
Authors: M Edginton; D Enarson; R Zachariah; T Reid; S Satyanarayana; K Bissell; S G Hinderaker; T Harries Journal: Public Health Action Date: 2012-03-21
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: Lancet Date: 2007-10-20 Impact factor: 79.321
Authors: G Benedetti; M Mossoko; J P Nyakio Kakusu; J Nyembo; J P Mangion; D Van Laeken; R Van den Bergh; W Van den Boogaard; M Manzi; W K Kibango; V Hermans; J Beijnsberger; V Lambert; E Kitenge Journal: Public Health Action Date: 2016-06-21
Authors: Kristen E McLean; Sharon Alane Abramowitz; Jacob D Ball; Josephine Monger; Kodjo Tehoungue; Sarah Lindley McKune; Mosoka Fallah; Patricia A Omidian Journal: Glob Public Health Date: 2016-07-27
Authors: Mateusz M Plucinski; Timothée Guilavogui; Sidibe Sidikiba; Nouman Diakité; Souleymane Diakité; Mohamed Dioubaté; Ibrahima Bah; Ian Hennessee; Jessica K Butts; Eric S Halsey; Peter D McElroy; S Patrick Kachur; Jamila Aboulhab; Richard James; Moussa Keita Journal: Lancet Infect Dis Date: 2015-06-23 Impact factor: 25.071
Authors: Maru Aregawi; Samuel J Smith; Musa Sillah-Kanu; John Seppeh; Anitta R Y Kamara; Ryan O Williams; John J Aponte; Andrea Bosman; Pedro Alonso Journal: Malar J Date: 2016-09-20 Impact factor: 2.979
Authors: Emily E White; Jordan Downey; Vidiya Sathananthan; Zahir Kanjee; Avi Kenny; Ami Waters; Jenny Rabinowich; Mallika Raghavan; Lorenzo Dorr; Amal Halder; Joseph Nyumah; Derry Duokie; Tamba Boima; Raj Panjabi; Mark J Siedner; John D Kraemer Journal: Am J Public Health Date: 2018-07-19 Impact factor: 9.308
Authors: Bradley H Wagenaar; Orvalho Augusto; Jason Beste; Stephen J Toomay; Eugene Wickett; Nelson Dunbar; Luke Bawo; Chea Sanford Wesseh Journal: PLoS Med Date: 2018-02-20 Impact factor: 11.069
Authors: Kristin Banek; Emily L Webb; Emily Bostick Doogue; Samuel Juana Smith; Daniel Chandramohan; Sarah G Staedke Journal: Malar J Date: 2021-01-21 Impact factor: 2.979